Literature DB >> 4601179

Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.

S Rabinovich, B D Shaw, T Bryant, S T Donta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4601179     DOI： 10.1093/infdis/130.1.28

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Synergism and antagonism among antimicrobial drugs. A personal perspective.

Authors:  E Jawetz
Journal:  West J Med       Date:  1975-08

Review 2.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

3.  Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.

Authors:  R L Kaspar; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

4.  Chemotherapy of experimental endogenous Candida albicans endophthalmitis.

Authors:  D B Jones
Journal:  Trans Am Ophthalmol Soc       Date:  1980

5.  Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.

Authors:  J W Van t Wout; H Mattie; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

6.  Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.

Authors:  M Kitahara; V K Seth; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

Review 7.  Antifungal agents used in systemic mycoses. Activity and therapeutic use.

Authors:  J R Graybill; P C Craven
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

8.  Neonatal systemic candidiasis.

Authors:  H Smith; P Congdon
Journal:  Arch Dis Child       Date:  1985-04       Impact factor: 3.791

Review 9.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

10.  In vivo efficacy of antifungal oxoaporphine alkaloids in experimental disseminated candidiasis.

Authors:  A M Clark; E S Watson; M K Ashfaq; C D Hufford
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.